Application of pelargonium extract in complicated course of acute respiratory infection of the upper airways

Nosulya E.V.; Kim I.A.; Luchsheva Yu.V.; Yushkina M.A.

doi:https://doi.org/10.17116/rosrino202432031216

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-3897-8384

Kim I.A.

N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency

ORCID: 0000-0003-1078-6388

Luchsheva Yu.V.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-8412-710X

Yushkina M.A.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

ORCID: 0000-0002-9823-1047

Application of pelargonium extract in complicated course of acute respiratory infection of the upper airways

Authors:

Nosulya E.V., Kim I.A., Luchsheva Yu.V., Yushkina M.A.

More about the authors

Journal: Russian Rhinology. 2024;32(3): 216‑222

DOI: 10.17116/rosrino202432031216

Read: 688 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Nosulya EV, Kim IA, Luchsheva YuV, Yushkina MA. Application of pelargonium extract in complicated course of acute respiratory infection of the upper airways. Russian Rhinology. 2024;32(3):216‑222. (In Russ.)
https://doi.org/10.17116/rosrino202432031216

Подписка 2026 Российская ринология (Russian Rhinology)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Treatment of acute respiratory infection (ARI), which in most cases has a viral etiology, is a challenging and ultimately unresolved task. Despite the availability of clinical guidelines (international and national), a wide range of existing means and methods of treatment, ARI is often the cause of unjustified prescription of antibiotics, which contributes to the increase of the selection tempo and spread of resistant strains of microorganisms in the populations, the frequency of adverse reactions that occur in a patient during treatment. In addition, the inflammatory process in ARI is often characterized by a complicated course that has a significant impact on the outcome of the disease. Therefore, the development of rational approaches to ARI treatment remains a topical area of clinical research.

OBJECTIVE

To analyze and summarize data on the therapeutic effectiveness of extract from the roots of Pelargonium sidoides (pelargonium) in ARI.

MATERIAL AND METHODS

The publications (articles and related abstracts) presented in the PubMed database were used. The choice of material was carried out according to the following keywords: cold, acute respiratory viral infection, diagnosis of acute sinusitis, phytotherapy of acute sinusitis, Pelargonium sidoides.

RESULTS AND CONCLUSION

The analysis of published results of clinical studies indicates the relevance of inclusion of the extract from the roots of Pelargonium sidoides in the ARI treatment protocols. The high safety profile and clinically significant effectiveness of this drug application allow it to be considered as an important component of comprehensive pharmacological therapy of ARI.

Keywords:

cold

acute respiratory viral infection

diagnosis of acute sinusitis

phytotherapy of acute sinusitis

Pelargonium sidoides

pelargonium extract

Authors:

Nosulya E.V.

Sverzhevky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-3897-8384

Kim I.A.

N.I. Pirogov Russian National Research Medical University;
National Medical Research Center of Otorhinolaryngology of Federal Medical-Biological Agency

ORCID: 0000-0003-1078-6388

Luchsheva Yu.V.

Sverzhevsky Research Clinical Institute of Otorhinolaryngology

ORCID: 0000-0002-8412-710X

Yushkina M.A.

N.I. Pirogov Russian National Research Medical University of the Ministry of Health of Russia;
Sverzhevsky Research Institute of Clinical Otorhinolaryngology

ORCID: 0000-0002-9823-1047

Received:

08.07.2024

Accepted:

20.07.2024

Close metadata

References:

Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect. 1993;110(1):145-160. https://doi.org/10.1017/s0950268800050779
Monto AS, Bryan ER, Ohmit S. Rhinovirus infections in Tecumseh, Michigan: frequency of illness and number of serotypes. J Infect Dis. 1987 Jul;156(1):43-49. https://doi.org/10.1093/infdis/156.1.43
Monto AS. The seasonality of rhinovirus infections and its implications for clinical recognition. Clin Ther. 2002 Dec;24(12):1987-1997. https://doi.org/10.1016/s0149-2918(02)80093-5
Arruda E, Pitkäranta A, Witek TJ Jr, Doyle CA, Hayden FG. Frequency and natural history of rhinovirus infections in adults during autumn. J Clin Microbiol. 1997 Nov;35(11):2864-2868. https://doi.org/10.1128/jcm.35.11.2864-2868.1997
Mäkelä MJ, Puhakka T, Ruuskanen O, Leinonen M, Saikku P, Kimpimäki M, Blomqvist S, Hyypiä T, Arstila P. Viruses and bacteria in the etiology of the common cold. J Clin Microbiol. 1998 Feb;36(2):539-542. https://doi.org/10.1128/JCM.36.2.539-542.1998
Van Cauwenberge PB, van Kempen MJ, Bachert C. The common cold. Acta Otorhinolaryngol Belg. 2000;54(3):397-401.
Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 1989 Mar 10;56(5):849-853. https://doi.org/10.1016/0092-8674(89)90689-2
Naclerio RM, Proud D, Lichtenstein LM, Kagey-Sobotka A, Hendley JO, Sorrentino J, Gwaltney JM. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988 Jan;157(1):133-142. https://doi.org/10.1093/infdis/157.1.133
Volovitz B, Faden H, Ogra PL. Release of leukotriene C4 in respiratory tract during acute viral infection. J Pediatr. 1988 Feb;112(2):218-222. https://doi.org/10.1016/s0022-3476(88)80058-1
Noah TL, Henderson FW, Wortman IA, Devlin RB, Handy J, Koren HS, Becker S. Nasal cytokine production in viral acute upper respiratory infection of childhood. J Infect Dis. 1995 Mar;171(3):584-592. https://doi.org/10.1093/infdis/171.3.584
Gwaltney JM. Clinical significance and pathogenesis of viral respiratory infections. Am J Med. 2002;112(Suppl 6A):13S-18S. https://doi.org/10.1016/s0002-9343(01)01059-2
Fendrick AM, Monto AS, Nightengale B, Sarnes M. The economic burden of non-influenza-related viral respiratory tract infection in the United States. Arch Intern Med. 2003 Feb;163(4):487-94. https://doi.org/10.1001/archinte.163.4.487
Eccles R. Mechanisms of symptoms of common cold and flu. In: Eccles R. Weber O. eds. Common Cold. Basel: Birkhäuser; 2009.
Arroll B. Common cold. BMJ Clin Evid. 2011;3:1510.
Cyr C, Racette R, Leduc CP, Blais C. Do symptoms and initial clinical probability predict the radiological diagnosis of acute sinusitis in children? Paediatr Child Health. 2001;6(8):536-539. https://doi.org/10.1093/pch/6.8.536
Taylor DG. Acute sore throat: discussing antibiotics with patients. BMJ. 2018 Jun;361:k2443. https://doi.org/10.1136/bmj.k2443
McIsaac WJ, White D, Tannenbaum D, Low DE. A clinical score to reduce unnecessary antibiotic use in patients with sore throat. CMAJ. 1998 Jan;158(1):75-83.
Hansen JG. Acute rhinosinusitis (ARS). Diagnosis and treatment of adults in general practice. Dan Med J. 2014;61(2):B4801.
Ebell MH, McKay B, Dale A, Guilbault R, Ermias Y. Accuracy of Signs and Symptoms for the Diagnosis of Acute Rhinosinusitis and Acute Bacterial Rhinosinusitis. Ann Fam Med. 2019;17(2):164-172. https://doi.org/10.1370/afm.2354
Nosulya EV, Kryukov AI, Kunel’skaya NL, Kim IA. Ostryj sinusit: aktual’nye voprosy terminologii i diagnostiki. Russian Bulletin of Otorhinolaryngology. 2021;86(3):72-77. (In Russ.).
Gwaltney JM Jr, Phillips CD, Miller RD, Riker DK. Computed tomographic study of the common cold. N Engl J Med. 1994;330(1):25-30. https://doi.org/10.1056/NEJM199401063300105
Alho OP, Ylitalo K, Jokinen K, Laitinen J, Suramo I, Tuokko H, Koskela M, Uhari M. The common cold in patients with a history of recurrent sinusitis: increased symptoms and radiologic sinusitislike findings. J Fam Pract. 2001;50(1):26-31.
Kalil J, Bowes J, Reddy D, Barrowman N, Le Saux N. Pediatric Inpatient Antimicrobial Stewardship Program Safely Reduces Antibiotic Use in Patients with Bronchiolitis Caused by Respiratory Syncytial Virus: A Retrospective Chart Review. Pediatr Qual Saf. 2019;4(5):e211. https://doi.org/10.1097/pq9.0000000000000211
van Houten CB, Cohen A, Engelhard D, Hays JP, Karlsson R, Moore E, et al. Antibiotic misuse in respiratory tract infections in children and adults – a prospective, multicentre study (TAILORED Treatment). Eur J Clin Microbiol. Infect Dis. 2019;38(3):505-514. https://doi.org/10.1007/s10096-018-03454-2
Hashimoto H, Matsui H, Sasabuchi Y, Yasunaga H, Kotani K, Nagai R, et al. Antibiotic prescription among outpatients in a prefecture of Japan, 2012–2013: a retrospective claims database study. BMJ Open. 2019 Apr;9(4):e026251.
Van Cauwenberge P, Watelet JB. Rôle des infections rhino-sinusiennes dans le déclenchement des pathologies allergiques et inflammatoires [Role of nasal sinus infections in the pathogenesis of allergic and inflammatory diseases]. Rev Fr Allergol Immunol Clin. 1998;38(4):258-263. (In French). https://doi.org/10.1016/S0335-7457(98)80038-5
Puhakka T, Mäkelä MJ, Malmström K, Uhari M, Savolainen J, Terho EO, Pulkkinen M, Ruuskanen O. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol. 1998 Jun;101(6 Pt 1):726-731. https://doi.org/10.1016/S0091-6749(98)70301-X
Henneicke-von Zepelin H, Hentschel C, Schnitker J, Kohnen R, Köhler G, Wüstenberg P. Efficacy and safety of a fixed combination phytomedicine in the treatment of the common cold (acute viral respiratory tract infection): results of a randomised, double blind, placebo controlled, multicentre study. Curr Med Res Opin. 1999;15(3):214-227. https://doi.org/10.1185/03007999909114094
Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial. Arch Intern Med. 2004 Jun;164(11):1237-1241. https://doi.org/10.1001/archinte.164.11.1237
Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(29):1-464. https://doi.org/10.4193/Rhin20.600
Kryukov AI, Kunel’skaya NL, Ivojlov AYu, Izotova GN, Luchsheva YuV, Machulin AI, Yanovskij VV, Arhangel’skaya II, Pakina VR, Morozova ZN. Klinicheskaya effektivnost’ Pelargonium sidoides – EPs® 7630 v kompleksnoj terapii detej s hronicheskim adenoiditom, perenesshih adenotomiyu. Medicinskij sovet. 2017;16:28-32. (In Russ.).
Kolodziej H. Antimicrobial, Antiviral and Immunomodulatory Activity Studies of Pelargonium sidoides (EPs 7630) in the Context of Health Promotion. Pharmaceuticals. 2011;4(10):1295-1314. https://doi.org/10.3390/ph4101295
Conrad A, Jung I, Tioua D, Lallemand C, Carrapatoso F, Engels I, Daschner FD, Frank U. Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine. 2007;14(Suppl 6):52-59. https://doi.org/10.1016/j.phymed.2006.11.018
Neugebauer P, Mickenhagen A, Siefer O, Walger M. A new approach to pharmacological effects on ciliary beat frequency in cell cultures: exemplary measurements under Pelargonium sidoides extract (EPs 7630). Phytomedicine: international journal of phytotherapy and phytopharmacology. 2005;12(1-2):46-51. https://doi.org/10.1016/j.phymed.2003.11.005
Perić A, Vezmar Kovačević S, Barać A, Gaćeša D, Perić AV, Vojvodić D. Effects of Pelargonium sidoides extract on chemokine levels in nasal secretions of patients with non-purulent acute rhinosinusitis. J Drug Assess. 2020 Nov;9(1):145-150. https://doi.org/10.1080/21556660.2020.1838176
Park SM, Min BG, Jung JY, Jegal KH, Lee CW, Kim KY, Kim YW, Choi YW, Cho IJ, Ku SK, Kim SC. Combination of Pelargonium sidoides and Coptis chinensis root inhibits nuclear factor kappa B-mediated inflammatory response in vitro and in vivo. BMC Complement Altern Med. 2018;18(1):20. https://doi.org/10.1186/s12906-018-2088-x
Kamin W, Funk P, Seifert G, Zimmermann A, Lehmacher W. EPs 7630 is effective and safe in children under 6 years with acute respiratory tract infections: clinical studies revisited. Current medical research and opinion. 2018;34(3):475-485. https://doi.org/10.1080/03007995.2017.1402754
Bereznoy VV, Riley DS, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther Health Med. 2003 Sep-Oct;9(5):68-79.
Bachert C, Schapowal A, Funk P, Kieser M. Treatment of acute rhinosinusitis with the preparation from Pelargonium sidoides EPs 7630: a randomized, double-blind, placebo-controlled trial. Rhinology. 2009;47(1):51-58.